Role of Tanashi Cream and Vati on Vyanga

A Comprehensive study of Tanashi Cream and Vati on Vyanga - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/066659

Enrollment

Registered

2024-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from classical clinical signs and symptoms of Vyanga. Patients of either sex between 15-45 age group.

Exclusion criteria

Exclusion criteria: Pregnant or breast feeding mother. Patients receiving hormone or corticosteroid therapy. Patients with history of endocrine disorders or allergies. Chronicity more than 10 years. Patients taking depigmenting or whitening products (oral or topical) within the previous 6 weeks will also a ground for exclusion. Patients below 15 years and above 45 years.

Design outcomes

Primary

Measure	Time frame
To reduce the signs and symptoms of vyanga and establish the efficacy of Tanashi Cream and VatiTimepoint: within 1 year	—

Secondary

Measure	Time frame
To observe reduction in Hyperpigmentation Area and Severity Index (HASI) score and formulate a good alternative to synthetic skin lightening creamTimepoint: within 1 year	—

Countries

India

Contacts

Public ContactDr Vaishali Gupta

Institute of Medical Sciences, Banaras Hindu University

anandayubhu@gmail.com9129221580

Outcome results